GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Vieira-Sousa, Elsa, Alves, Pedro, Rodrigues, Ana M, Teixeira, Filipa, Tavares-Costa, Jose, Bernardo, Alexandra, Pimenta, Sofia, Pimentel-Santos, Fernando M, Gomes, João Lagoas, Aguiar, Renata, Pinto,Том:
79
Журнал:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2019-216500
Date:
April, 2020
Файл:
PDF, 641 KB
2020
File converter
Більше результатів пошуку
More benefits 
